CLINICAL EFFICACY OF ORAL BUDESONIDE FOR INDUCTION OF REMISSION IN COLLAGENOUS COLITIS: RESULTS FROM THE OPEN-LABEL INDUCTION PHASE OF BUC-63/COC

(1) University hospital

(2) Medilab

(3) Regional hospital

(4) Center for Digestive Disease

(5) Privite practice

(6) Dr. Falk Pharma GmbH



This item was part of the New pharmacological treatment options for lower GI diseases session at 20th United European Gastroenterology Week

This item can be cited as: Gut 2012; 61 (Suppl 3) A102

You may be interested in:

Case discussion: Severe intestinal dysmotility
English, Clinical aspects, Investigation and Diagnosis, Gastrointestinal motility, Syllabus contribution, Narcotic Bowel Syndrome, 2013
Severe functional GI disease: Severe intestinal dysmotility
English, Presentation, Clinical aspects, Aetiology / Causes, Behaviour/Psych. interventions, Classification, Brain-gut and gut-brain axes, neuro-hormonal, neuralimmune and visceral sensitivity, Narcotic Bowel Syndrome, Neuropathy, 2013

Categorisation:

  • Format
    • Abstract
  • Language
    • English
  • Year
    • 2012